Delivery luteolin with folacin-modified nanoparticle for glioma therapy
Cong Wu, Qian Xu, Xinyue Chen, Jiagang Liu Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaCorrespondence: Jiagang LiuDepartment of Neurosurgery, West China Hospital, West China Medical School, Sichua...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/446dd61f16fb4a43b6a4c78705d1b1ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:446dd61f16fb4a43b6a4c78705d1b1ff |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:446dd61f16fb4a43b6a4c78705d1b1ff2021-12-02T04:45:09ZDelivery luteolin with folacin-modified nanoparticle for glioma therapy1178-2013https://doaj.org/article/446dd61f16fb4a43b6a4c78705d1b1ff2019-09-01T00:00:00Zhttps://www.dovepress.com/delivery-luteolin-with-folacin-modified-nanoparticle-for-glioma-therap-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Cong Wu, Qian Xu, Xinyue Chen, Jiagang Liu Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaCorrespondence: Jiagang LiuDepartment of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaTel +86 288 542 2136Fax +86 288 550 2796Email jiagang_liu@163.comBackground: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability.Patients and methods: In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo.Results: When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL.Conclusion: These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention.Keywords: luteolin, PEG-PCL, glioma, folic acid, apoptosisWu CXu QChen XLiu JDove Medical PressarticleLuteolinPEG-PCLgliomafolic acidapoptosis.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7515-7531 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Luteolin PEG-PCL glioma folic acid apoptosis. Medicine (General) R5-920 |
spellingShingle |
Luteolin PEG-PCL glioma folic acid apoptosis. Medicine (General) R5-920 Wu C Xu Q Chen X Liu J Delivery luteolin with folacin-modified nanoparticle for glioma therapy |
description |
Cong Wu, Qian Xu, Xinyue Chen, Jiagang Liu Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaCorrespondence: Jiagang LiuDepartment of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaTel +86 288 542 2136Fax +86 288 550 2796Email jiagang_liu@163.comBackground: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability.Patients and methods: In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo.Results: When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL.Conclusion: These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention.Keywords: luteolin, PEG-PCL, glioma, folic acid, apoptosis |
format |
article |
author |
Wu C Xu Q Chen X Liu J |
author_facet |
Wu C Xu Q Chen X Liu J |
author_sort |
Wu C |
title |
Delivery luteolin with folacin-modified nanoparticle for glioma therapy |
title_short |
Delivery luteolin with folacin-modified nanoparticle for glioma therapy |
title_full |
Delivery luteolin with folacin-modified nanoparticle for glioma therapy |
title_fullStr |
Delivery luteolin with folacin-modified nanoparticle for glioma therapy |
title_full_unstemmed |
Delivery luteolin with folacin-modified nanoparticle for glioma therapy |
title_sort |
delivery luteolin with folacin-modified nanoparticle for glioma therapy |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/446dd61f16fb4a43b6a4c78705d1b1ff |
work_keys_str_mv |
AT wuc deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy AT xuq deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy AT chenx deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy AT liuj deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy |
_version_ |
1718401080926142464 |